Stay Informed | Change The Cycle | Medical Professionals

How Can the Myosure Procedure Help With Infertility?

The MyoSure Procedure and Fertility

The MyoSure tissue removal system demonstrated real-world effectiveness for improving the success of fertility treatments for certain patients by removing fibroids, polyps, and other tissue from the uterus before beginning fertility treatment.¹

What are Retained Products of Conception?

Retained products of conception (RPOC) may occur after miscarriage, pregnancy termination, or delivery.² The MyoSure system is a solution for the removal of RPOC, because it provides direct visualization so that your doctor can target the RPOC directly and remove it. If your doctor has determined that you have RPOC, then ask if the MyoSure procedure may be the right treatment option for you.

References

1. Vaishali Bhalani, M.D., Andrew Change, M.D., Christen Adkins, M.D., Seren H. Chen, M.D., M.P.H. Fertility outcomes after hysteroscopic morcellation of intrauterine leiomyomas and polyps. J Reprod Med. 2016;61(4):327-335 2. Smorgick N, Barel O, Fuchs N, Ben-Ami I, Pansky M, Vaknin Z; Hysteroscopic management of retained products of conception: meta-analysis and literature review. European Journal of Obstetrics & Gynecology and Reproductive Biology 173 2014 19-22

IMPORTANT SAFETY INFORMATION

The MyoSure^® tissue removal system, consisting of the MyoSure tissue removal devices (LITE, REACH, XL) and MyoSure controller, is intended for hysteroscopic intrauterine procedures by trained gynecologists to resect and remove tissue including submucous myomas, endometrial polyps, and retained products of conception. The MyoSure MANUAL hysteroscopic tissue removal device is intended for intrauterine use by a trained gynecologist to hysteroscopically resect and remove tissue, including focal lesions such as endometrial polyps and retained products of conception. MyoSure products are not appropriate for patients who are or may be pregnant, or are exhibiting pelvic infection, cervical malignancies, or previously diagnosed uterine cancer.

For more details on risks and benefits of the MyoSure system, MyoSure MANUAL tissue removal device, MyoSure hysteroscope and the Aquilex^® fluid control system, please consult their respective IFUs.

The Fluent^® fluid management system is intended to provide liquid distension of the uterus during diagnostic and operative hysteroscopy, and to monitor the volume differential between the irrigation fluid flowing into and out of the uterus while providing drive, control and suction for hysteroscopic morcellators.

The Fluent fluid management system may not be used to introduce fluids into the uterus when hysteroscopy is contraindicated. The system should not be used to remove pathologies from pregnant patients or patients exhibiting pelvic infection, cervical malignancies, or previously diagnosed endometrial cancer. For detailed benefit and risk information, including contraindications relative to endometrial ablation, please consult the Instructions For Use.

About Hologic | Privacy | Terms

© 2018 Hologic, Inc. All Rights Reserved